cetuximab - Samachar Central

Treatment Choices for Atopic Dermatitis

2023-11-17 02:10 AM

This transcript has been edited for clarity. Steven R. Feldman, MD, PhD: Hi. I’m Dr Steve Feldman, professor of dermatology at the Wake Forest University School of Medicine in Winston-Salem, North Carolina. Peter Lio, MD: And I’m Dr Peter Lio. I’m a clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of …

Impressive Bleeding Profile With Factor XI Inhibitor in AF

2023-11-14 03:35 AM

xFurther details from the phase 2b AZALEA trial with the factor XI inhibitor abelacimab (Anthos) show significant reductions in major and clinically relevant nonmajor bleeding compared with rivaroxaban for patients with AF; the risk of stroke was moderate to high. The trial was stopped earlier this year because of an “overwhelming” reduction in bleeding with …